Haemonetics Sets Date for Publishing Second Quarter Fiscal Year 2021 Results: November 4, 2020

Haemonetics Corporation (NYSE:HAE) announced that the Company intends to publish second quarter fiscal year 2021 financial results at 6:00 am EDT on Wednesday, November 4, 2020 . The Company will hold a conference call with investors and analysts to discuss results and answer questions at 8:00 am EDT on November 4 , 2020.

BOSTON, Oct. 6, 2020 /PRNewswire/ -- Haemonetics Corporation (NYSE:HAE) announced that the Company intends to publish second quarter fiscal year 2021 financial results at 6:00 am EDT on Wednesday, November 4, 2020. The Company will hold a conference call with investors and analysts to discuss results and answer questions at 8:00 am EDT on November 4, 2020.

The call can be accessed with the following information:

U.S. / Canada toll free (877) 848-8880; International (716) 335-9512
Conference ID required for access: 3899118

A live webcast of the call can be accessed on Haemonetics’ investor relations website. Webcast Link: https://edge.media-server.com/mmc/p/ge7vnpw8

Webcast replay will be available from November 4, 2020 11:00 am to November 12, 2020 11:00 am EDT.

About Haemonetics

Haemonetics (NYSE: HAE) is a global healthcare company dedicated to providing a suite of innovative hematology products and solutions for customers to help them improve patient care and reduce the cost of healthcare. Our technologies address important medical markets: blood and plasma component collection, the surgical suite, and hospital transfusion services. To learn more about Haemonetics, visit www.haemonetics.com.

Investor Contact:

Media Contact:

Olga Guyette, Director-Investor Relations

Carla Burigatto, VP-Global Communications

(781) 356-9763

(781) 348-7263

olga.guyette@haemonetics.com

carla.burigatto@haemonetics.com

Cision View original content to download multimedia:http://www.prnewswire.com/news-releases/haemonetics-sets-date-for-publishing-second-quarter-fiscal-year-2021-results-november-4-2020-301147049.html

SOURCE Haemonetics Corporation


Company Codes: NYSE:HAE
MORE ON THIS TOPIC